Represents potential penetration into ~ 20% of the U.S. institutional market, while broadening access across long-term care and outpatient facilities U.S. losartan market totals $256M annually with ...
Scienture Holdings, Inc. announced GPO agreements for its new drug, Arbli, providing access to over 2,500 healthcare ...
The recent repeal of the Windfall Elimination Provision (WEP) and Government Pension Offset (GPO) marks a significant shift ...
Premier has entered a five-year group purchasing agreement with Premier Infusion and Healthcare Services expected to exceed an estimated $50 million in annual contract ...